BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9195045)

  • 1. Purification of an atypical bovine interferon induced in response to heat shock in bovine cultured cells. Characterization in comparison with the classical alpha, beta and gamma interferon.
    Gachet Y; Carpentier G; Chousterman S
    Biochimie; 1997; 79(1):43-52. PubMed ID: 9195045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',5'-Oligoadenylate synthetase expression is induced in response to heat shock.
    Chousterman S; Chelbi-Alix MK; Thang MN
    J Biol Chem; 1987 Apr; 262(10):4806-11. PubMed ID: 2435717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction of atypical interferon after heat shock].
    Gachet Y; La Bonnardière C; Thang MN; Chousterman S
    C R Acad Sci III; 1993; 316(4):337-40. PubMed ID: 7691386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol induces 2',5'-oligoadenylate synthetase and antiviral activities through interferon-beta production.
    Chelbi-Alix MK; Chousterman S
    J Biol Chem; 1992 Jan; 267(3):1741-5. PubMed ID: 1309794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
    Ohmann HB; Campos M; Griebel PJ; Babiuk LA
    Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
    Justesen J; Berg K
    J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
    Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
    J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
    Fraioli M; Wu JM
    J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro.
    Witt PL; Marié I; Robert N; Irizarry A; Borden EC; Hovanessian AG
    J Interferon Res; 1993 Feb; 13(1):17-23. PubMed ID: 8454907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human gamma interferon on cell growth, replication of virus and induction of 2'-5'oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells.
    Tomita Y; Cantell K; Kuwata T
    Int J Cancer; 1982 Aug; 30(2):161-5. PubMed ID: 6182110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2'5'A synthetase in the bovine system: preliminary characterization.
    Vanden Broecke C; Plasman PO; Hauzeur K; Goossens A; Ligongo G; Piscitelli S; Werenne J
    Prog Clin Biol Res; 1985; 202():339-44. PubMed ID: 2421312
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral and antiproliferative activity of human interferons and their induction of 2',5'-oligoadenylate synthetase].
    Krispin TI; Itkes AV; Balandin IG; Solov'eva MF; Kuznetsov VP
    Mol Gen Mikrobiol Virusol; 1986 Apr; (4):42-6. PubMed ID: 2432419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance to human interferon-gamma of human interferon-beta-resistant F-IFr cells.
    Morinaga N; Yonehara S; Kuwata T
    J Gen Virol; 1984 Jun; 65 ( Pt 6)():1113-7. PubMed ID: 6327895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP induces in HT-29 cells 2'5'oligoadenylate synthetase and antiviral state via interferon beta/alpha synthesis.
    Chelbi-Alix MK; Boissard C; Sripati CE; Rosselin G; Thang MN
    Peptides; 1991; 12(5):1085-93. PubMed ID: 1724797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo 2',5'-oligoadenylate synthetase activity induced by recombinant DNA-derived bovine interferon alpha I1 in bovine alveolar macrophages and blood mononuclear cells.
    Holland SP; Fulton RW; Short EC; Wyckoff JH; Fox JC
    Am J Vet Res; 1991 Nov; 52(11):1779-83. PubMed ID: 1664669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lung cancer nodules in organotypic culture: no evidence of correlation between the antiproliferative effects of interferons and the induction of 2',5'-oligoadenylate synthetase.
    Martyré MC; Beaupain R; Falcoff E
    Tumour Biol; 1988; 9(5):263-9. PubMed ID: 2461579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
    Mestan J; Brockhaus M; Kirchner H; Jacobsen H
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple molecular forms of interferon display different specific activities in the induction of the antiviral state and 2'5' oligoadenylate synthetase.
    Chelbi-Alix MK; Thang MN
    Biochem Biophys Res Commun; 1986 Dec; 141(3):1042-50. PubMed ID: 3028383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.